Serial plasma concentrations of adiponectin, leptin, and resistin during therapy in children with acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 1, 2010, Pages e8-e13

  Moschovi, Maria ^a   Trimis, Georgios ^a   Vounatsou, Maria ^a   Katsibardi, Katerina ^a   Margeli, Alexandra ^a   Damianos, Andreas ^a   Chrousos, George ^b   Papassotiriou, Ioannis ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute lymphoblastic leukemia; Adiponectin; Body mass index; Leptin; Resistin

Indexed keywords

ADIPONECTIN; ANTINEOPLASTIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADIPONECTIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; LEPTIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RESISTIN; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 75749106298     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b8a50c     Document Type: Article

References (33)

1. Calabro P, Yeh ET. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Subcell Biochem. 2007;42: 63-91.
2. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol. 2007;2: 31-56.
3. Frankenberry KA, Somasundar P, Mcfadden DW, et al. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg. 2004;188: 560-565.
4. Brakenhielm E, Veitonmaki N, Cao R, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA. 2004;101: 2476-2481.
5. MacInnis RJ, English DR, Hopper JL, et al. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst. 2005;97: 1154-1157.
6. Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc Nutr Soc. 2008;67: 128-145.
7. Mantzoros C, Petridou E, Dessypris N, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 2004;89: 1102-1107.
8. Tzortzatou-Stathopoulou F, Moschovi MA, Papadopoulou AL, et al. Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors? Eur J Haematol. 2005;75: 361-369.
9. Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, et al. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. J Pediatr Hematol Oncol. 2001;23: 591-597.
10. Van der Velden VH, Boeckx N, van Wering ER, et al. Detection of minimal residual disease in acute leukemia. J Biol Regul Homeost Agents. 2004;18: 146-154.
11. Spyridopoulos TN, Petridou ET, Skalkidou A, et al. Obesity and Cancer Oncology Group. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer. 2007;120: 1573-1578.
12. Barb D, Williams CJ, Neuwirth AK, et al. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2007;86: s858-s866.
13. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51: 1884-1888.
14. Nishihara T, Baba M, Matsuda M, et al. Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol. 2008;14: 6473-6480.
15. Arditi JD, Venihaki M, Karalis KP, et al. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res. 2007;39: 9-13.
16. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257: 79-83.
17. Syrenicz A, Garanty-Bogacka B, Syrenicz M, et al. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuro Endocrinol Lett. 2006;27: 453-458.
18. Guzik TJ, Mangalat D, Korbut R. Adipocytokines-novel link between inflammation and vascular function? J Physiol Pharmacol. 2006;57: 505-528.
19. Dalamaga M, Nikolaidou A, Karmaniolas K, et al. Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study. Oncology. 2007;73: 26-32.
20. Petridou E, Mantzoros CS, Dessypris N, et al. Adiponectin in relation to childhood myeloblastic leukemia. Br J Cancer. 2006;94: 156-160.
21. Siahanidou T, Margeli A, Lazaropoulou C, et al. Circulating adiponectin in preterm infants fed long-chain polyunsaturated fatty acids (LCPUFA)-supplemented formula-a randomized controlled study. Pediatr Res. 2008;63: 428-432.
22. Moschovi M, Trimis G, Apostolakou F, et al. Serum lipid alterations in acute lymphoblastic leukemia in childhood. J Pediatr Hematol Oncol. 2004;26: 289-293.
23. Patel SB, Reams GP, Spear RM, et al. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep. 2008;10: 131-137.
24. Piestrzeniewicz K, £uczak K, Komorowski J, et al. Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction. Metabolism. 2008;57: 488-493.
25. Karapanagiotou EM, Tsochatzis EA, Dilana KD, et al. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer. 2008;61: 391-397.
26. Pamuk GE, Demir M, Harmandar F, et al. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp Oncol. 2006;28: 241-244.
27. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68: 437-446.
28. La Cava A, Matarese G. The weight of leptin in immunity. Nature Reviews. 2004;4: 371-379.
29. Ribeiro R, Araújo A, Lopes C, et al. Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator? J Thorac Oncol. 2007;2: 105-108.
30. Konopleva M, Mikhail A, Estrov Z, et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 1999;93: 1668-1676.
31. Moschovi M, Trimis G, Vounatsou M, et al. Serial plasma concentrations of PYY and ghrelin during chemotherapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008;30: 733-737.
32. Rieth N, Jollin L, Le Panse B, et al. Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men. Eur J Appl Physiol. 2009;105: 309-313.
33. Hjelmesaeth J, Flyvbjerg A, Jenssen T, et al. Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol. 2006;1: 575-582.